MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Topic
Psoriasis: Treatment and Pathogenesis
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

2,393 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
2,393 works in the cohort · of 4,299,418page 22 of 48

Labels cover 8 of 2,393 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 2,393 of 2,393 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affunlabeled
Considerations for defining and diagnosing generalized pustular psoriasis
Vimal H. Prajapati, Charles Lynde, Melinda Gooderham, Chih-ho Hong, Mark G. Kirchhof, Perla Lansang +5 more
2024· review· en· Journal of the European Academy of Dermatology and Venereology· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
11
citations
affunlabeled
Quality of life and patient‐perceived symptoms in patients with psoriasis undergoing proactive or reactive management with the fixed‐dose combination Cal/BD foam: A <i>post‐hoc</i> analysis of PSO‐LONG
Ahmad Jalili, Piergiacomo Calzavara‐Pinton, Leon Kircik, Dominique Lons‐Danic, Andrew Pink, Stephen K. Tyring +7 more
2021· article· en· Journal of the European Academy of Dermatology and Venereology· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
10
citations
venueno affunlabeled
Translational Perspectives on Psoriatic Arthritis
Christopher T. Ritchlin, Steven T. Proulx, Edward M. Schwarz
2009· review· en· Journal of Rheumatology Supplement· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
10
citations
afffundno abstractunlabeled
OP0228 EFFICACY AND SAFETY OF RISANKIZUMAB FOR ACTIVE PSORIATIC ARTHRITIS, INCLUDING PATIENTS WITH INADEQUATE RESPONSE OR INTOLERANCE TO BIOLOGIC THERAPIES: 24-WEEK RESULTS FROM THE PHASE 3, RANDOMIZED, DOUBLE-BLIND, KEEPSAKE 2 TRIAL
Andrew J.K. Östör, Filip Van den Bosch, Kim Papp, Cecilia Asnal, Ricardo Blanco, Jacob Aelion +6 more
2021· article· en· Annals of the Rheumatic Diseases· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
10
citations
aboutno affno abstractunlabeled
Resetting the Research Agenda for Psoriasis
R.J.G. Chalmers, C.E.M. Griffiths
2003· letter· en· Journal of Investigative Dermatology· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
10
citations

How this was built: Screen · Findings · About